12:00 AM
Dec 05, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Asahi Kasei sales and marketing update

Asahi launched Teribone teriparatide in Japan to treat osteoporosis in patients with a high risk of fracture. The National Health Insurance...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >